Author | Danny Rischin, MD, MBBS, FRACP | OncLive

Author | Danny Rischin, MD, MBBS, FRACP

Articles

Dr. Rischin on the FDA Approval of Cemiplimab for CSCC

September 29, 2018

Video

Danny Rischin, MD, director, Division of Cancer Medicine, head, Department of Medical Oncology, Peter MacCallum Cancer Centre, discusses the FDA approval of cemiplimab for the treatment of patients with cutaneous squamous cell carcinoma.

x